FZFujie ZhangMD, PhDSlidesetHIVChinese HIV Clinical Forum 2022Fujie Zhang - HIV Low-Level Viremia and New Approach to Drug Resistance SurveillanceView Slideset
MBMarta BoffitoMD, PhD, FRCP, MBASlidesetHIVChinese HIV Clinical Forum 2022Marta Boffito - Stopping/Switching Considerations When Using La-ARVsView Slideset
LDLili DaiPhDSlidesetHIVChinese HIV Clinical Forum 2022Lili Dai - Rapid ART Initiation Using BIC/FTC/TAF and TDF+3TC+EFV in HIV Positive Patients in China: A Randomized Controlled TrialView Slideset
PPPraphan PhanuphakMD, PhDSlidesetHIVRSVAsia-Pacific HIV Clinical Forum 2022Early Diagnosis and Same-day ARTView Slideset
SKSasisopin KiertiburanakulMD, MHSSlidesetHIVRSVAsia-Pacific HIV Clinical Forum 2022Sasisopin Kiertiburanakul - Resistance Considerations in Choice of RegimenView Slideset
SGSivaporn GatechompolMDSlidesetHIVRSVAsia-Pacific HIV Clinical Forum 2022International and Asian Country Guidelines - Similarities and Differences - Sivaporn Gatechompol, MDView Slideset
NPNittaya PhanuphakMD, PhDSlidesetHIVRSVAsia-Pacific HIV Clinical Forum 2022Update on Pharmacologic Options for HIV Prevention - Nittaya Phanupak, MD, PhDView Slideset
NKNagalingeswaran KumarasamyMD, FRCP, PhDSlidesetHIVRSVAsia-Pacific HIV Clinical Forum 2022Therapeutic Options for Starting Antiretroviral Therapy - Nagalingeswaran Kumarasamy, MDView Slideset
TCTim CresseyMSc, PhDSlidesetHIVRSVAsia-Pacific HIV Clinical Forum 2022Pharmacological Considerations in Choice of Regimen - Tim Cressey, MSc, PhDView Slideset
LLLinghua LiMD, PhDSlidesetHIVRSVAsia-Pacific HIV Clinical Forum 2022Management of Major Comorbidity in the Region - Linghua Li, MD, PhDView Slideset
NPNicholas PatonMD, FRCPSlidesetHIVRSVAsia-Pacific HIV Clinical Forum 2022Constructing an Effective Treatment Regimen after ART Failure - Nicholas Paton, MD, FRCPView Slideset
SBSazali BasriMBBS, MMedSlidesetHIVRSVAsia-Pacific HIV Clinical Forum 2022Clinical Case (Focused on Treatment Switching) - Sazali Basri, MBBS, MMedView Slideset
